[1]刘 瑜,王建强,古俊楠,等.房颤合并功能性二尖瓣返流研究[J].医学信息,2019,32(15):51-53.[doi:10.3969/j.issn.1006-1959.2019.15.017]
　LIU Yu,WANG Jian-qiang,GU Jun-nan,et al.Study on Atrial Fibrillation Combined with Functional Mitral Regurgitation[J].Journal of Medical Information,2019,32(15):51-53.[doi:10.3969/j.issn.1006-1959.2019.15.017]
点击复制

房颤合并功能性二尖瓣返流研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年15期
页码:
51-53
栏目:
综述
出版日期:
2019-08-01

文章信息/Info

Title:
Study on Atrial Fibrillation Combined with Functional Mitral Regurgitation
文章编号:
1006-1959（2019）15-0051-03
作者:
刘 瑜1; 王建强1; 古俊楠1; 张牧秋1; 李 超2
1.首都医科大学，北京 100054；2.北京同仁医院，北京 100176
Author(s):
LIU Yu1; WANG Jian-qiang1; GU Jun-nan1; ZHANG Mu-qiu1; LI Chao2
1.The University of Capital Medical,Beijing 100054,China; 2.Beijing Tongren Hospital,Beijing 100176,China
关键词:
心房颤动; 二尖瓣返流; 功能性二尖瓣返流
Keywords:
Key words：Atrial fibrillation; Mitral regurgitation; Functional mitral regurgitation
分类号:
R540.45
DOI:
10.3969/j.issn.1006-1959.2019.15.017
文献标志码:
A
摘要:
随着人口老龄化的加剧，功能性二尖瓣返流的发病率越来越高，已经成为最常见的瓣膜性疾病之一。而目前发现房颤患者往往合并二尖瓣返流，称为心房功能性二尖瓣返流，该类患者恢复窦性心律后二尖瓣返流症状往往会得到改善。但房颤与二尖瓣返流之间的关系尚不清楚，也缺乏房颤合并功能性二尖瓣返流患者治疗方案的相关指南推荐。本文就房颤与功能性二尖瓣返之间的联系、相关的评估和治疗方案进行综述。
Abstract:
Abstract：With the aging of the population, the incidence of functional mitral regurgitation is increasing, and it has become one of the most common valvular diseases. At present, patients with atrial fibrillation often have mitral regurgitation, which is called atrial functional mitral regurgitation. These patients often have improved mitral regurgitation after restoring sinus rhythm. However, the relationship between atrial fibrillation and mitral regurgitation is unclear, and there is a lack of guidelines for the treatment of patients with atrial fibrillation complicated with functional mitral regurgitation. This article reviews the links between AF and functional mitral regurgitation, related assessments, and treatment options.

参考文献/References:

[1]Nishimura RA,Otto CM,Bonow RO,et al.2014 AHA/ACC guideline for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J].J Thorac Cardiovasc Surg,2014,148(1):e1-e132. [2]Nkomo VT,Gardin JM,Skelton TN,et al.Burden of valvular heart diseases:a population-based study[J].Lancet,2006,368(9540):1005-1011. [3]Enriquezsarano M,Akins CW,Vahanian A.Mitral regurgitation[J].American Journal of Cardiology,2009,45(3):720. [4]Alexopoulos D,Vlachakis P,Lekakis J.Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI:a Fading Role[J].Cardiovasc Drugs Ther,2017,31(3):319-324. [5]Kihara T,Gillinov AM,Takasaki K,et al.Mitral regurgitation associated with mitral annular dilation in patients with lone atrial fibrillation:an echocardiographic study[J].Echocardiography,2009,26(8):885-889. [6]Gertz ZM,Raina A,Saghy L,et al.Evidence of atrial functional mitral regurgitation due to atrial fibrillation:reversal with arrhythmia control[J].J Am Coll Cardiol,2011,58(14):1474-1481. [7]Saito C,Minami Y,Arai K,et al.Prevalence,clinical characteristics,and outcome of atrial functional mitral regurgitation in hospitalized heart failure patients with atrial fibrillation[J].J Cardiol,2018,72(4):292-299. [8]Bertrand PB,Schwammenthal E,Levine RA,et al.Exercise Dynamics in Secondary Mitral Regurgitation:Pathophysiology and Therapeutic Implications[J].Circulation,2017,135(3):297-314. [9]Ducas RA,White CW,Wassef AW,et al.Functional mitral regurgitation: current understanding and approach to management[J].Can J Cardiol,2014,30(2):173-180. [10]van Rosendael PJ,Katsanos S,Kamperidis V,et al.New insights on Carpentier I mitral regurgitation from multidetector row computed tomography[J].Am J Cardiol,2014,114(5):763-768. [11]Sharma S,Lardizabal J,Monterroso M,et al.Clinically unrecognized mitral regurgitation is prevalent in lone atrial fibrillation[J].World Journal of Cardiology,2012,4(5):183-187. [12]Grigioni F,Benfari G,Vanoverschelde JL,et al.Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation[J].J Am Coll Cardiol,2019,73(3):264-274. [13]Liang JJ,Silvestry FE.Mechanistic insights into mitral regurgitation due to atrial fibrillation:"Atrial functional mitral regurgitation"[J].Trends Cardiovasc Med,2016,26(8):681-689. [14]Kim DH,Heo R,Handschumacher MD,et al.Mitral Valve Adaptation to Isolated Annular Dilation: Insights Into the Mechanism of Atrial Functional Mitral Regurgitation[J].JACC Cardiovasc Imaging,2019,12(4):665-677. [15]Li B,Luo F,Luo X,et al.Effects of atrial fibrosis induced by mitral regurgitation on atrial electrophysiology and susceptibility to atrial fibrillation in pigs[J].Cardiovasc Pathol,2019(40):32-40. [16]Qiao Y,Wu L,Hou B,et al.Functional mitral regurgitation: predictor for atrial substrate remodeling and poor ablation outcome in paroxysmal atrial fibrillation[J].Medicine (Baltimore),2016,95(30):e4333. [17]Nishimura RA,Otto CM,Bonow RO,et al.2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J].J Am Coll Cardiol,2017,70(2):252-289. [18]Faletra FF,Berrebi A,Pedrazzini G,et al.3D transesophageal echocardiography: A new imaging tool for assessment of mitral regurgitation and for guiding percutaneous edge-to-edge mitral valve repair[J].Prog Cardiovasc Dis,2017,60(3):305-321. [19]Chen SC,Lee WH,Hsu PC,et al.Association of the Ratio of Early Mitral Inflow Velocity to the Global Diastolic Strain Rate with a Rapid Renal Function Decline in Atrial Fibrillation[J].PLoS One,2016,11(1):e147446. [20]van der Bijl P,Vo NM,Leung M,et al.Impact of atrial fibrillation on improvement of functional mitral regurgitation in cardiac resynchronization therapy[J].Heart Rhythm,2018,15(12):1816-1822. [21]Udo EO,Hassink RJ,Udo EO,et al.Pulmonary vein isolation as a treatment for severe atrial functional mitral regurgitation in a patient with atrial fibrillation[J].International Journal of Cardiology,2014,175(3):578-579. [22]Vohra HA,Whistance RN,Magan A,et al.Mitral valve repair for severe mitral regurgitation secondary to lone atrial fibrillation[J].Eur J Cardiothorac Surg,2012,42(4):634-637.

相似文献/References:

[1]姜亦瑶,王 凯,施 超.心肌纤维化引发心房颤动的研究进展[J].医学信息,2018,31(12):28.[doi:10.3969/j.issn.1006-1959.2018.12.010]
　JIANG Yi-yao,WANG Kai,SHI Chao.Research Progress of Atrial Fibrillation Caused by Myocardial Fibrosis[J].Journal of Medical Information,2018,31(15):28.[doi:10.3969/j.issn.1006-1959.2018.12.010]
[2]王淑娟,林祥灿.血浆NT-proBNP水平与同型半胱氨酸对 糖尿病合并心房颤动的相关性研究[J].医学信息,2018,31(14):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
　WANG Shu-juan,LIN Xiang-can.Correlation between Plasma NT-proBNP level and Homocysteine in Patients with Diabetes Mellitus Complicated with Atrial Fibrillation[J].Journal of Medical Information,2018,31(15):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
[3]陶春艳.柔性护理在胺碘酮治疗心房颤动护理中的应用研究[J].医学信息,2018,31(24):154.[doi:10.3969/j.issn.1006-1959.2018.24.046]
　TAO Chun-yan.Application of Flexible Nursing in the Treatment of Atrial Fibrillation with Amiodarone[J].Journal of Medical Information,2018,31(15):154.[doi:10.3969/j.issn.1006-1959.2018.24.046]
[4]古俊楠,张牧秋,王建强,等.可穿戴设备在心房颤动诊治中的应用[J].医学信息,2019,32(15):34.[doi:10.3969/j.issn.1006-1959.2019.15.012]
　GU Jun-nan,ZHANG Mu-qiu,WANG Jian-qiang,et al.Application of Wearable Devices in the Diagnosis and Treatment of Atrial Fibrillation[J].Journal of Medical Information,2019,32(15):34.[doi:10.3969/j.issn.1006-1959.2019.15.012]
[5]张牧秋,古俊楠,刘 瑜,等.NOACS治疗房颤合并急性冠脉综合征的研究[J].医学信息,2019,32(13):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
　ZHANG Mu-qiu,GU Jun-nan,LIU Yu,et al.Study of NOACS in the Treatment of Atrial Fibrillation Complicated with Acute Coronary Syndrome[J].Journal of Medical Information,2019,32(15):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
[6]王建强,刘 瑜,张牧秋,等.房颤伴ACS患者经皮冠状动脉介入术后抗栓研究[J].医学信息,2019,32(14):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
　WANG Jian-qiang,LIU Yu,ZHANG Mu-qiu,et al.Study on Antithrombotic after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation and ACS[J].Journal of Medical Information,2019,32(15):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
[7]朱文书,张理想,游杨杨,等.长链非编码RNA MIAT表达水平与心房颤动导管消融术后复发的关系[J].医学信息,2021,34(04):75.[doi:10.3969/j.issn.1006-1959.2021.04.020]
　ZHU Wen-shu,ZHANG Li-xiang,YOU Yang-yang,et al.Relationship Between the Expression Level of Long Non-coding RNA MIAT and Recurrence After Catheter Ablation of Atrial Fibrillation[J].Journal of Medical Information,2021,34(15):75.[doi:10.3969/j.issn.1006-1959.2021.04.020]
[8]马 利,李丽华.aVR导联法在心房颤动伴宽QRS波群心动过速鉴别诊断中的应用[J].医学信息,2022,35(19):142.[doi:10.3969/j.issn.1006-1959.2022.19.041]
　MA Li,LI Li-hua.Application of aVR Lead Method in Differential Diagnosis of Atrial Fibrillation with Wide QRS Complex Tachycardia[J].Journal of Medical Information,2022,35(15):142.[doi:10.3969/j.issn.1006-1959.2022.19.041]
[9]陈启松,何海军,谷光敏,等.IL-6基因多态性与心房颤动相关性的Meta分析[J].医学信息,2020,33(23):73.[doi:10.3969/j.issn.1006-1959.2020.23.021]
　CHEN Qi-song,HE Hai-jun,GU Guang-min,et al.Meta Analysis of the Correlation Between IL-6 Gene Polymorphism and Atrial Fibrillation[J].Journal of Medical Information,2020,33(15):73.[doi:10.3969/j.issn.1006-1959.2020.23.021]
[10]梁桂琤,钟国强,李金轶.心房颤动与认知障碍的相关性研究[J].医学信息,2020,33(20):21.[doi:10.3969/j.issn.1006-1959.2020.20.007]
　LIANG Gui-cheng,ZHONG Guo-qiang,LI Jin-yi.Study on the Correlation Between Atrial Fibrillation and Cognitive Impairment[J].Journal of Medical Information,2020,33(15):21.[doi:10.3969/j.issn.1006-1959.2020.20.007]
[11]张定欣,林先和.经食道三维超声在房颤二尖瓣结构变化对其 返流程度影响中的应用[J].医学信息,2018,31(12):76.[doi:10.3969/j.issn.1006-1959.2018.12.023]
　ZHANG Ding-xin,LIN Xian-he.Application of Transesophageal Three-dimensional Ultrasound in the Influence of Mitral Valve Structure Changes on the Degree of Reflux in Atrial Fibrillation[J].Journal of Medical Information,2018,31(15):76.[doi:10.3969/j.issn.1006-1959.2018.12.023]

更新日期/Last Update: 2019-08-01